Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for Scleroderma-Associated Raynaud's Syndrome
NCT02165111Phase 3Completed
- Sponsor
- Johns Hopkins University
- Start
- Jan 2015
- Primary completion
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in Raynaud phenomenon, sponsored by Johns Hopkins University. Started Jan 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Raynaud phenomenon
Beyond the preview
Go deeper on NCT02165111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02165111.